Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Sayuk

Gastroenterology Saint Louis, MO Medical Doctor

NPI 1760494280 CMS profile 216479

915 N Grand Blvd, Saint Louis, MO 63106

Open in the dashboard

General payments

$1,063,765

916 records reported · program years 2019–2025

Research payments

$7,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Sayuk of Saint Louis, MO is reported in the CMS Open Payments database as having received $1,063,765 across 916 general payments and $7,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $265,465 182
2025 Research $7,500 1
2024 General $314,534 251
2023 General $150,407 127
2022 General $75,977 51
2021 General $51,885 32
2020 General $35,820 27
2019 General $169,677 246

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Sayuk
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Gregory Sayuk were reported at $265,465. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Gregory Sayuk Gastroenterology median Middle half National median
2019 $169,677 $417 $126–$1,100 $163
2020 $35,820 $224 $74–$624 $114
2021 $51,885 $352 $106–$1,054 $132
2022 $75,977 $448 $129–$1,270 $149
2023 $150,407 $533 $150–$1,390 $160
2024 $314,534 $605 $160–$1,606 $164
2025 $265,465 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $263,990 142 payments
  2. Salix Pharmaceuticals, a division of Bausch Health US, LLC $235,729 231 payments
  3. Regeneron Healthcare Solutions, Inc. $138,464 95 payments
  4. Allergan Inc. $117,485 175 payments
  5. Ardelyx, Inc. $103,919 94 payments
  6. Phathom Pharmaceuticals, Inc. $98,169 108 payments
  7. AbbVie, Inc. $82,312 55 payments
  8. Alnylam Pharmaceuticals Inc. $11,826 5 payments
  9. Ironwood Pharmaceuticals, Inc $9,658 9 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $2,006 1 payment
  11. Other $208 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $677,172 178 payments
  2. Consulting Fee $122,797 51 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $101,936 21 payments
  4. Travel and Lodging $79,139 351 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $56,600 18 payments
  6. Food and Beverage $23,322 296 payments
  7. Education $2,800 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $243,827 134 payments
  2. LINZESS $139,434 180 payments
  3. XIFAXAN $114,628 123 payments
  4. IBSRELA $101,119 93 payments
  5. VOQUEZNA $98,169 108 payments
  6. VIBERZI $95,582 129 payments
  7. TRULANCE Gastroenterology $69,697 52 payments
  8. TRULANCE Gastroenterology $49,292 59 payments
  9. DUPIXENT Inflammation And Immunology $40,926 26 payments
  10. DUPIXENT Immunology And Inflammation $32,612 30 payments
  11. Other $15,868 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Ardelyx, Inc. $7,500 1 payment

Records

917 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record